NYSE International 100
8.315,95
PKT
+33,35
PKT
+0,40
%
Werbung
Analysen zu NYSE International 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
09.01.23 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
09.01.23 | GSK Equal Weight | Barclays Capital | |
09.01.23 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
09.01.23 | AstraZeneca Overweight | Barclays Capital | |
09.01.23 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
09.01.23 | Nutrien (Ex Potash Agrium) Underperform | Credit Suisse Group | |
09.01.23 | SAP Underperform | Jefferies & Company Inc. | |
09.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
09.01.23 | AstraZeneca Neutral | UBS AG | |
09.01.23 | Sanofi Neutral | UBS AG | |
09.01.23 | Novartis Neutral | UBS AG | |
09.01.23 | GSK Sell | UBS AG | |
09.01.23 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
09.01.23 | Allianz Overweight | Morgan Stanley | |
09.01.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
09.01.23 | Eni Buy | Goldman Sachs Group Inc. | |
09.01.23 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
09.01.23 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
09.01.23 | SAP Overweight | JP Morgan Chase & Co. | |
07.01.23 | UBS Neutral | Credit Suisse Group | |
06.01.23 | Deutsche Bank Underperform | Credit Suisse Group | |
06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
06.01.23 | Novartis Underperform | Credit Suisse Group | |
06.01.23 | Sanofi Outperform | Credit Suisse Group | |
06.01.23 | GSK Neutral | Credit Suisse Group | |
06.01.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
06.01.23 | Sanofi Equal-weight | Morgan Stanley | |
06.01.23 | Unilever Buy | Jefferies & Company Inc. | |
06.01.23 | HSBC Buy | Jefferies & Company Inc. | |
06.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
06.01.23 | SAP Underperform | Jefferies & Company Inc. | |
06.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
06.01.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
06.01.23 | Novartis Underweight | Morgan Stanley | |
06.01.23 | UBS Outperform | RBC Capital Markets | |
06.01.23 | Deutsche Bank Outperform | RBC Capital Markets | |
05.01.23 | UBS Overweight | JP Morgan Chase & Co. | |
05.01.23 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
05.01.23 | Deutsche Telekom Overweight | Barclays Capital |